Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Name: Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
License: Public Domain

Emory University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

localized colon carcinoma, stage iib colon cancer ajcc v8, stage iic colon cancer ajcc v8, stage iii colon cancer ajcc v8

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272341
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.